Results 71 to 80 of about 2,723 (121)

Oligogenic Familial Hypercholesterolemia Treated by Combination Therapy of Statin, Ezetimibe, PCSK9 Inhibitor, and Lomitapide. [PDF]

Intern Med
Kojima N, Tada H, Takamura M.
europepmc   +1 more source

Impact of Antihypertensive, Antihyperlipidemic, and Mixed Antidepressant Medications on Dental Implant Success: A Retrospective Cohort Study. [PDF]

Cureus
Chidiac A, Kachouh C, M Sadaka R, Bassil J.   +3 more
europepmc   +1 more source

PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in acute coronary syndromes (REPRESS): study protocol for a multicentre randomised controlled trial. [PDF]

BMJ Open
Chen Z, Ma S, Zhang J, Zhang R, Zhou M, Li C, Chen Y, Wang H, He Y, REPRESS trial investigator.   +9 more
europepmc   +1 more source

Prevalence and Medical Treatment of Arterial Hypertension and Hypercholesterolemia in Germany: a Nationwide questionnaire-based Survey in Medical Practices. [PDF]

High Blood Press Cardiovasc Prev
Beger C, Randerath O, Mayerböck A, Klein K, Limbourg FP.   +4 more
europepmc   +1 more source

Pilot study of the use of ezetimibe in dogs with hyperlipidemia. [PDF]

Vet Res Commun
de Lima Wachholz P, Bierhals ES, de Lima CM, Grala CX, de Freitas VR, Jorge S, Bruhn FRP, de Oliveira Nobre M, Rondelli MCH.   +8 more
europepmc   +1 more source

Pharmacokinetic comparison of ezetimibe/rosuvastatin/telmisartan 10/20/80 mg fixed-dose combination versus coadministration of separate tablets in healthy participants. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Goh S, Huh KY, Lee S, Cho JY, Yu KS.
europepmc   +1 more source

Obicetrapib: There is still Life in the CETP Inhibitor! [PDF]

J Atheroscler Thromb
Ogura M.
europepmc   +1 more source

Switching to rosuvastatin plus ezetimibe in statin-treated stroke patients with low-density lipoprotein cholesterol levels above 70 mg/dL (SWITCH): a prospective observational study. [PDF]

Lipids Health Dis
Yang W, Lee YB, Kim EG, Cho HJ, Yu S, Kim JT, Shin JW, Lee SJ, Kim BJ, Hong JM, Koh SH, An SJ, Cho AH, Jung JM, Cho HJ, Kim C, Lee EJ, Kim JM, Lee SH.   +18 more
europepmc   +1 more source

Low-Density Lipoprotein Cholesterol Target Attainment in Lithuania: A Nationwide Analysis of Real-World Health Data. [PDF]

Medicina (Kaunas)
Urbonas G, Lapinskas T, Čeponienė I, Vasiliauskienė O, Umbrasienė J, Grabauskytė I, Plisienė J.   +6 more
europepmc   +1 more source

Methodological Challenges of Emulating a Target Trial to Assess Effectiveness of Timing of PCSK9 Inhibitor Treatment Initiation Post Myocardial Infarction. [PDF]

Pharmacoepidemiol Drug Saf
Cars T, Gustafsson S, Chan Q, Dhalwani N, Kent ST, Briggs A, Gale CP, Gitt A, Jukema JW, Steg PG, Sundström J, James S, Hagström E, Brookhart MA.   +13 more
europepmc   +1 more source